Funder: Leiomyosarcoma Support & Direct Research Foundation
Due Dates (Anticipated): August 2027 (Project abstract, anticipated)
Funding Amounts: Typically $50,000–$100,000 per year for one or two years ($200,000 maximum)
Summary: Supports new leiomyosarcoma research to improve diagnosis, identify prognostic markers, and advance treatments.
Key Information: Institutional fiscal-manager confirmation is required that funds will not support investigator salary or institutional facilities and administrative costs.
Description
The Leiomyosarcoma Support & Direct Research Foundation (LMSDR) invites investigators to propose research specifically studying leiomyosarcoma. The Foundation is particularly interested in basic science and translational work that improves understanding of the molecular biology of both uterine and non-uterine disease. Its goals include better diagnostic tools, new prognostic markers, and novel therapeutic approaches that extend survival and improve quality of life.
Funding is intended primarily for promising new work, with priority given to projects offering the greatest potential impact on treatments. LMSDR also supports grants that contribute to career development. Its Science Advisory Board reviews detailed applications and recommends projects to the Foundation’s Board of Trustees, which makes final funding decisions.
